Olaparib
Olaparib is a compound that functions as a poly(ADP-ribose) polymerase (PARP) inhibitor, used in pharmaceutical manufacturing. It is a member of the N-acylpiperazine class and is employed as an antineoplastic agent, specifically as an apoptosis inducer via inhibition of NAD(+) ADP-ribosyltransferase.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 763113-22-0
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate
4-{[4-fluoro-3-(piperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate for olaparib synthesis
4-{[4-fluoro-3-(4-nitrosopiperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
nitrosamine impurity reference standard
DL-Methamphetamine
active pharmaceutical ingredient
2,4-Quinazolinediamine, N2-(3-aminopropyl)-6,7-dimethoxy-N2-methyl-
alfuzosin related substance impurity
Enalaprilat
active pharmaceutical ingredient
N-((1R)-1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-L-proline
active pharmaceutical ingredient
4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
FDLYAMZZIXQODN-UHFFFAOYSA-N
C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F